Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 24, 2023

Clinical Outcomes of LZM005 in Patients With HER2-Positive Metastatic Breast Cancer

NPJ breast cancer


Additional Info

NPJ breast cancer
Phase I study of LZM005 in patients with HER2-positive metastatic breast cancer
NPJ Breast Cancer 2022 Dec 27;8(1)132, C Xue, H Li, H Yao, Y Lin, X An, M Chen, R Huang, L Li, A Hu, M Ni, L Zhang, W Yang, Z Xu, S Li, Y Shi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading